1129 — Nashville, Tennessee

1129 is a clinical research site located in Nashville, Tennessee, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

1129 has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer.

Sponsors: PharmaMar.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1129?

1129 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1129 conducted?

1129 has 1 clinical trials on record. Their work covers Ovarian Cancer.

Is 1129 accredited by Crixeo Health?

1129 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1129?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.